glp-1 asa medications safe to continue before surgery in patients with diabetes and obesity ASA: Hold GLP-1 Agonists Before

Artificial sweeteners, whether sucralose, stevia, aspartame or any of the other increasing number of ingredients being added to this category, are being linked to just as many negative health problems as sugar, in its many forms, according to a new review of five years' worth of research

Modern vein treatments are minimally invasive, performed as an outpatient in a comfortable office setting, and require little to no downtime

Most GLP-1 agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) do not require dose adjustment for mild-to-moderate renal impairment, though caution is warranted in severe renal impairment

Insulin drugs and GLP-1 receptor agonists are utilized as crucial therapeutic options in diabetes management and obesity treatment throughout Europe

We also integrate nutrition guidance, behavior coaching, and meal-planning support to ensure you get the most out of your treatment